ATE161527T1 - Methode zur solubilisierung organischer verbindungen in lipophilen systemen ,neue chemische komplexe solcher verbindungen und verschiedene anwendungen dieser komplexe - Google Patents

Methode zur solubilisierung organischer verbindungen in lipophilen systemen ,neue chemische komplexe solcher verbindungen und verschiedene anwendungen dieser komplexe

Info

Publication number
ATE161527T1
ATE161527T1 AT95912148T AT95912148T ATE161527T1 AT E161527 T1 ATE161527 T1 AT E161527T1 AT 95912148 T AT95912148 T AT 95912148T AT 95912148 T AT95912148 T AT 95912148T AT E161527 T1 ATE161527 T1 AT E161527T1
Authority
AT
Austria
Prior art keywords
complexes
fatty acid
pct
carbon atoms
acid moiety
Prior art date
Application number
AT95912148T
Other languages
English (en)
Inventor
Morten Sloth Weidner
Original Assignee
Morten Sloth Weidner
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=8091955&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ATE161527(T1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Morten Sloth Weidner filed Critical Morten Sloth Weidner
Application granted granted Critical
Publication of ATE161527T1 publication Critical patent/ATE161527T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/54—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic compound
    • A61K47/542—Carboxylic acids, e.g. a fatty acid or an amino acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/54—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic compound
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders

Landscapes

  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Dermatology (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Fodder In General (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Medicinal Preparation (AREA)
  • Cosmetics (AREA)
  • Fats And Perfumes (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
AT95912148T 1994-03-14 1995-03-14 Methode zur solubilisierung organischer verbindungen in lipophilen systemen ,neue chemische komplexe solcher verbindungen und verschiedene anwendungen dieser komplexe ATE161527T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DK29694 1994-03-14

Publications (1)

Publication Number Publication Date
ATE161527T1 true ATE161527T1 (de) 1998-01-15

Family

ID=8091955

Family Applications (1)

Application Number Title Priority Date Filing Date
AT95912148T ATE161527T1 (de) 1994-03-14 1995-03-14 Methode zur solubilisierung organischer verbindungen in lipophilen systemen ,neue chemische komplexe solcher verbindungen und verschiedene anwendungen dieser komplexe

Country Status (13)

Country Link
US (1) US6087391A (de)
EP (1) EP0750604B1 (de)
JP (1) JP3802927B2 (de)
CN (1) CN1114589C (de)
AT (1) ATE161527T1 (de)
AU (1) AU680355B2 (de)
BR (1) BR9507080A (de)
DE (1) DE69501325T2 (de)
ES (1) ES2113738T3 (de)
GR (1) GR3026479T3 (de)
HU (1) HU222373B1 (de)
RU (1) RU2145320C1 (de)
WO (1) WO1995025084A1 (de)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2767062B1 (fr) * 1997-08-11 2000-03-17 Andre Pierre Morice Composition comprenant de la propolis
US7939115B2 (en) * 2000-06-12 2011-05-10 Access Business Group International Llc Dietary supplement and related method
US7416749B2 (en) * 2000-06-12 2008-08-26 Access Business Group International Llc Dietary supplement and related method
US7438936B2 (en) * 2000-06-12 2008-10-21 Access Business Group International Llc Dietary supplement and related method
DE20122900U1 (de) * 2001-07-12 2009-12-03 Aquanova Ag Ubichinon Konzentrat
WO2004000333A1 (en) * 2002-06-20 2003-12-31 Astion Dermatology A/S Novel complexes of fatty acid esters of polyhydroxyalkanes and pyridine carboxy derivatives
US20040195549A1 (en) 2003-04-04 2004-10-07 Clifford Adams Lipid-soluble formulations containing mixtures of antioxidants
DK2192160T3 (en) * 2008-12-01 2016-12-12 Aquanova Ag INTEGRATED oxidation of micelles FOR NATURAL DYES
GB2633109B (en) * 2023-10-27 2025-11-26 Golden Ahm Ltd Method of forming a liposome comprising a derivative of curcumin

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS53107408A (en) * 1977-02-28 1978-09-19 Yamanouchi Pharmaceut Co Ltd Micellar preparation for rectal infusion
US4582715A (en) * 1984-12-04 1986-04-15 The Procter & Gamble Company Acylated glycerides useful in low calorie fat-containing food compositions
ES2071332T3 (es) * 1990-08-13 1995-06-16 David W Yesair Particulas coloidales de lipidos mixtos-bicarbonato para administrar farmacos o calorias.
WO1992008450A2 (fr) * 1990-11-12 1992-05-29 Fileco UTILISATION ANTIVIRALE DE COMPOSE 2,6-DI-t-BUTYLPHENOL SUBSTITUE EN POSITION 4, NOTAMMENT VIS-A-VIS DES VIRUS DE L'HERPES ET DES PAPILLOMAVIRUS

Also Published As

Publication number Publication date
DE69501325T2 (de) 1998-09-03
RU2145320C1 (ru) 2000-02-10
JP3802927B2 (ja) 2006-08-02
CN1114589C (zh) 2003-07-16
AU680355B2 (en) 1997-07-24
JPH09510224A (ja) 1997-10-14
WO1995025084A1 (en) 1995-09-21
BR9507080A (pt) 1997-09-16
HUT76420A (en) 1997-08-28
US6087391A (en) 2000-07-11
DE69501325D1 (de) 1998-02-05
CN1143949A (zh) 1997-02-26
AU1945995A (en) 1995-10-03
HU222373B1 (hu) 2003-06-28
HU9602513D0 (en) 1996-11-28
EP0750604A1 (de) 1997-01-02
ES2113738T3 (es) 1998-05-01
GR3026479T3 (en) 1998-06-30
EP0750604B1 (de) 1997-12-29

Similar Documents

Publication Publication Date Title
BR0107069A (pt) Composição nutricional, usos de uma composição e de uma fórmula enriquecida de nutriente
EP1961312A3 (de) Mischung von mikrobiellen Ölen und deren Verwendungen
KR900002784A (ko) 항종양치료에 사용하기 위한 약제학적 결합제제
AU3706493A (en) Nutritional comosition containing a low ph form of an amino acid
AU2054399A (en) New piperazinyl-substituted pyridylalkane, alkene and alkine carboxamides
ATE73657T1 (de) Verwendung von gamma-linolensaeure und verwandten verbindungen zur herstellung eubnes arzneimittels zur behandlung von endometriose.
AU5431390A (en) Novel arylpyridazines, their manufacture, use and medicaments containing them
ATE119033T1 (de) Eine dispersion von lipidvesikeln enthaltende kosmetika oder arznei- bzw. nahrungsmittel.
HUT50842A (en) Process for producing new diphosphonic acid derivatives and pharmaceutical compositions comprising same
MX166379B (es) Composicion absorbente que contiene compuestos amino severamente impedidos y sales de amina, con un proceso para la absorcion de h2s usando la misma composicion
DE69501325D1 (de) Methode zur solubilisierung organischer verbindungen in lipophilen systemen ,neue chemische komplexe solcher verbindungen und verschiedene anwendungen dieser komplexe
ZA9811240B (en) New aryl-substituted pyridylalkane alkene and alkine carboxamides
PL316942A1 (en) Novel pharmaceutic compositions based on taxoides
EP0344880A3 (en) Pharmaceutical compositions with anti-cancer activity and method for the treatment of cancer
MY109434A (en) Fluoroaliphatic dimer acid derivatives and use thereof
AU1910892A (en) Polycarbonates and the use thereof for the preparation of bioerosible matrices
KR890003391A (ko) 칼슘 보충제
TW364905B (en) Lactone compound and process of production thereof
DE19680202D2 (de) Arzneistoffe zur selektiven Bekämpfung von Tumorgewebe
RU96118607A (ru) Способ получения растворимых в жировых системах химических комплексов на основе органических соединений, новые химические комплексы таких соединений, а также различные применения этих комплексов
ZA93275B (en) Pseudopeptide compounds having bradykinin-antagonist activity, process for preparing them and pharmaceutical compositions containing them.
AU2953697A (en) Vitamin d analogs and methods of preparing these compounds
EP0537634A3 (de)
HU904582D0 (en) Process for producing amino-oligohydroxi derivatives and pharmaceutical preparatives containing those compounds
ATE55123T1 (de) Alkylcarbonsaeureamide von pyridinalkylaminen, ihre herstellung und ihre verwendung als arzneimittel.

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification
EEIH Change in the person of patent owner